Under the contract, for the first project, Telstar will manage the construction of a plant for the production of oral solids consisting of a four-story building of 32,000 m2 with 7 fluidized bed granulation lines, 11 tablet lines, 4 lines for capsules, and 16 primary and secondary packaging lines, plus a second service building of 1,000m²
Telstar will also provide development services for the second project consists of a 20,000m² four-story building for production of parenterals in small and large volume formats.
The parenterals in small and large volume formats include two lines for manufacturing BFS bottles with two reactors of 20,000 litres each, a line for manufacturing glass bottles, one for bags, two for vials, two for preloaded syringes, one for lyophilized vials with two freeze-dryers and one topical aerosol production line.
Square Pharma anticipates the start up of the new plants in the first half of 2013.